217 related articles for article (PubMed ID: 19169878)
1. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
[TBL] [Abstract][Full Text] [Related]
2. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
3. Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.
Saxena R; Chawla YK; Verma I; Kaur J
J Interferon Cytokine Res; 2014 Feb; 34(2):117-28. PubMed ID: 24161121
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
5. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
[TBL] [Abstract][Full Text] [Related]
6. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Kim YJ; Lee HS; Im JP; Min BH; Kim HD; Jeong JB; Yoon JH; Kim CY; Kim MS; Kim JY; Jung JH; Kim LH; Park BL; Shin HD
Exp Mol Med; 2003 Jun; 35(3):196-202. PubMed ID: 12858019
[TBL] [Abstract][Full Text] [Related]
7. No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
Qi P; Wang H; Chen YM; Sun XJ; Liu Y; Gao CF
Pathology; 2009; 41(6):555-60. PubMed ID: 19900104
[TBL] [Abstract][Full Text] [Related]
8. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
9. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
10. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on polymorphism at -509 C/T site of TGF-β1 gene in patients with keloids].
Song M; Liu Y
Zhonghua Shao Shang Za Zhi; 2014 Dec; 30(6):482-6. PubMed ID: 25608783
[TBL] [Abstract][Full Text] [Related]
12. -509C>T polymorphism in the TGF-β1 gene promoter is not associated with susceptibility to and progression of colorectal cancer in Chinese.
Qi P; Ruan CP; Wang H; Zhou FG; Zhao YP; Gu X; Gao CF
Colorectal Dis; 2010 Nov; 12(11):1153-8. PubMed ID: 19863608
[TBL] [Abstract][Full Text] [Related]
13. Relationships between the Osteocalcin gene polymorphisms, serum osteocalcin levels, and hepatitis B virus-related hepatocellular carcinoma in a Chinese population.
Liu Y; Huang L; Lu Y; Xi XE; Huang XL; Lu Q; Huang X; Li S; Qin X
PLoS One; 2015; 10(1):e0116479. PubMed ID: 25587715
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S
Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406
[TBL] [Abstract][Full Text] [Related]
15. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
16. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
17. The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV.
Yao X; Zeng H; Zhang G; Zhou W; Yan Q; Dai L; Wang X
Biomed Res Int; 2013; 2013():953974. PubMed ID: 23586065
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.
Xin Z; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
Mol Carcinog; 2012 Oct; 51 Suppl 1():E123-31. PubMed ID: 22290546
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
Li W; Wu H; Song C
Tumour Biol; 2013 Oct; 34(5):2675-81. PubMed ID: 23653379
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of the
He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
